Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive tags : Presentation save search
NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting
Published: 2024-04-18 (Crawled : 13:00) - neurosense.investorroom.com
NRSN | $1.51 -5.63% -5.96% 270K
|
|
| O: -2.5%
H: 0.0%
C: 0.0%
neurology presentation readout positive topline meeting
TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
TFFP | $3.2405 -9.69% 26K
|
Health Technology
|
| O: 0.25%
H: 1.26%
C: -11.56%
tacrolimus presentation positive sessions pharmaceuticals trial
Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties
Published: 2024-04-10 (Crawled : 12:30) - prnewswire.com
MBRX | $4.59 7.24% 6.75% 50K
|
Health Technology
|
| O: 8.8%
H: 3.87%
C: -8.61%
presentation positive
REVALESIO ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 RESCUE STUDY OF RNS60 IN PATIENTS WITH ACUTE ISCHEMIC STROKE IN LATE-BREAKING ORAL PRESENTATION AT ISC 2024
Published: 2024-02-07 (Crawled : 23:00) - biospace.com/
LLY | News | $745.95 -0.64% -0.1% 1.7M
|
Health Technology
|
| O: 0.76%
H: 4.31%
C: 2.11%
rns60 stroke presentation positive topline study
Syndax Presents Positive Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at Late-Breaking Oral Presentation During 65th ASH Annual Meeting
Published: 2023-12-12 (Crawled : 17:00) - prnewswire.com
SNDX | $20.44 -1.45% -1.47% 1.2M
|
Health Technology
|
| O: -0.56%
H: 1.57%
C: -0.95%
gment-101 presentation positive meeting leukemia trial
Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023
Published: 2023-12-10 (Crawled : 16:20) - globenewswire.com
JSPR | $23.28 -2.27% -2.32% 120K
|
| Email alert
Add to watchlist
presentation positive cell aml therapeutics results study
Jasper Therapeutics Announces Oral Presentation of Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant at ASH 2023
Published: 2023-11-02 (Crawled : 13:00) - globenewswire.com
JSPR | $23.28 -2.27% -2.32% 120K
|
|
| O: -5.24%
H: 10.87%
C: 6.39%
presentation positive cell aml therapeutics results study
Orchard Therapeutics Announces Presentation of Additional Positive Data from Proof-of-concept Study of OTL-203 in MPS-IH at ESGCT 2023
Published: 2023-10-26 (Crawled : 11:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 0.0%
H: 0.06%
C: 0.0%
otl-203 presentation positive mps-ih therapeutics study
Update: Halozyme Announces Presentation of Positive Clinical Data of its High-Volume Auto-Injector Demonstrating Successful Rapid Subcutaneous Drug Delivery at 13th Annual PODD: Partnership Opportunities in Drug Delivery Conference
Published: 2023-10-16 (Crawled : 19:00) - prnewswire.com
HALO M | $37.84 -0.47% -0.48% 790K
|
Health Technology
|
| O: -1.32%
H: 4.47%
C: 2.85%
partnership drug conference rapid presentation positive
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
Published: 2023-09-06 (Crawled : 14:00) - biospace.com/
NAOV 4 | $0.75 0.61% 3.5K
|
Health Technology
|
| O: -3.18%
H: 6.2%
C: -5.47%
presentation positive meeting results uroshield
Precision BioSciences Announces Oral Presentation of Positive ARCUS® Gene Editing Data at International Liver Congress 2023
Published: 2023-06-22 (Crawled : 12:00) - precisionbiosciences.com
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 1.69%
H: 1.67%
C: -3.18%
arcus liver presentation positive international
Vera Therapeutics Announces Positive Week 36 Efficacy and Safety Results of Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN in Late-Breaking Presentation at 60th European Renal Association (ERA) Congress
Published: 2023-06-17 (Crawled : 16:20) - globenewswire.com
VERA | $39.51 -1.25% -1.27% 860K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
association renal presentation origin positive week trial therapeutics results igan
Actinium Announces Positive Pivotal Phase 3 SIERRA Trial Results in an Oral Presentation at the EHA 2023 Congress
Published: 2023-06-12 (Crawled : 11:00) - prnewswire.com
ATNM | $6.67 -8.0% 1.2% 420K
|
Health Technology
|
| O: 2.05%
H: 1.18%
C: -1.66%
presentation positive trial results
Artelo Biosciences Selected for Oral Presentation to Report Positive Research Findings on ART12.11 at the 33rd Annual International Cannabinoid Research Society Symposium
Published: 2023-06-07 (Crawled : 12:00) - globenewswire.com
ARTL | $1.29 -1.9% -1.94% 14K
|
Health Technology
|
| O: 2.11%
H: 10.76%
C: 7.99%
art12 report symposium presentation positive research
Zentalis Announces Presentation of Positive Phase 1b Data Demonstrating Durable Responses and Favorable Safety Profile of Azenosertib in Combination with Chemotherapy at the 2023 ASCO Annual Meeting
Published: 2023-05-25 (Crawled : 21:00) - globenewswire.com
ZNTL | $12.55 -1.26% -1.27% 680K
|
Health Technology
|
| O: 0.15%
H: 10.66%
C: 10.48%
presentation asco favorable positive meeting
AlloVir Announces Positive Results Including Long-Term Mortality Data in Phase 2 Posoleucel Multi-Virus Prevention Study in Oral Presentation at EBMT 2023
Published: 2023-04-26 (Crawled : 12:00) - biospace.com/
ALVR | $0.74 -2.23% -2.28% 530K
|
Health Technology
|
| O: 3.16%
H: 7.52%
C: -1.95%
presentation positive results study
Moleculin Announces Presentation of Positive Pharmacokinetics and Tissue-Organ Distribution Data Demonstrating High Antitumor Activity of Annamycin in Preclinical Cancer Models
Published: 2023-04-18 (Crawled : 18:00) - prnewswire.com
MBRX | $4.59 7.24% 6.75% 50K
|
Health Technology
|
| O: 1.6%
H: 73.68%
C: -9.79%
distribution presentation positive cancer preclinical
Pieris Pharmaceuticals Announces Presentation of Positive Clinical Data for Cinrebafusp Alpa (PRS-343) At 2023 AACR Annual Meeting
Published: 2023-04-17 (Crawled : 13:00) - biospace.com/
PIRS | $0.157 -0.06% -0.06% 620K
|
Health Technology
|
| O: 10.01%
H: 5.32%
C: 4.43%
prs-343 presentation positive pharmaceuticals meeting
Beyond Air® Announces Positive Data for Inhaled Nitric Oxide (NO) to Treat COVID-19 with LungFit® PRO in a Poster Presentation at IDWeek 2022
Published: 2022-10-24 (Crawled : 12:00) - globenewswire.com
XAIR | $1.175 -8.2% -8.94% 610K
|
Technology Services
|
| O: 0.59%
H: 6.99%
C: 4.37%
covid-19 air presentation positive
Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatment at the EASL International Liver Congress™
Published: 2022-06-25 (Crawled : 16:20) - prnewswire.com
IONS | $40.81 -0.24% -0.25% 990K
|
Health Technology
| Email alert
Add to watchlist
treatment hepatitis liver presentation positive international phase 2b chronic hepatitis b
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.